Margaret (Maggie) M. FitzPatrick
Board Member
AN2 Therapeutics, Inc. (ANTX)Equibles does not estimate personal net worth.
Get an email with a short summary when AN2 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANTX alertsAbout Margaret (Maggie) M. FitzPatrick
Margaret (Maggie) M. FitzPatrick is recorded as Board Member at AN2 Therapeutics, Inc. (ANTX) since May 5, 2022. AN2 Therapeutics, Inc. reported in an 8-K filed May 9, 2022 that Margaret (Maggie) M. FitzPatrick was appointed Class II Director, effective May 5, 2022. AN2 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at AN2 Therapeutics, Inc. includes Eric Easom (CEO and Board Member), Lucy Day (CFO and Chief Accounting Officer), Josh Eizen (COO) and 7 others.
“On May 5, 2022, Margaret (Maggie) M. FitzPatrick was appointed to the board of directors (the “Board”) of AN2 Therapeutics, Inc., a Delaware corporation (the “Company”), as a Class II Director, whose initial term will end at the Company’s 2024 Annual Meeting of Stockholders and was also appointed to the nominating and corporate governance committee of the Board.”
Affiliation history
-
Current
2022-05-05–present
Company network
Leadership on record at AN2 Therapeutics, Inc.
- Eric Easom CEO, Board Member
- Lucy Day CFO, Chief Accounting Officer
- Josh Eizen COO
- Joshua Eizen COO, General Counsel
- Sarah Williams Chief Accounting Officer
- Gilbert Lynn Marks Board Member
- Joseph Zakrzewski Board Member
- Kabeer Aziz Board Member
- Margaret FitzPatrick Board Member
- Melvin Spigelman Board Member